Evidence map›Paper›PMID 26822783›Full record

ArticleParasites & vectors2016

Baseline prevalence and intensity of schistosomiasis at sentinel sites in Madagascar: Informing a national control strategy.

Clara Fabienne Rasoamanamihaja, Alain Marcel Rahetilahy, Bruno Ranjatoarivony, Neerav Dhanani, Luciano Andriamaro, Samuel Hermas Andrianarisoa, Peter Mark Jourdan

Open access · goldAbstract read
In one paragraph

Article in Parasites & vectors, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Schistosomiasis with a Focus on Africa.Tropical medicine and infectious disease · 2021
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Clara Fabienne RasoamanamihajaMinistry of Public Health, Antananarivo, Madagascar. clarafabienner@gmail.com.
Alain Marcel RahetilahyMinistry of Public Health, Antananarivo, Madagascar. alainrahetilahy@yahoo.fr.
Bruno RanjatoarivonyMinistry of National Education, Antananarivo, Madagascar. ranjatoarivonyb@yahoo.fr.
Neerav DhananiSchistosomiasis Control Initiative (SCI), Imperial College London, London, UK. n.dhanani@imperial.ac.uk.
Luciano AndriamaroRéseau International Schistosomose Environnement Aménagement et Lutte (RISEAL) Madagascar, Antananarivo, Madagascar. landriamaro@conservation.org.
Samuel Hermas AndrianarisoaWorld Health Organization (WHO) Madagascar, Antananarivo, Madagascar. andrianarisoas@who.int.
Peter Mark JourdanSchistosomiasis Control Initiative (SCI), Imperial College London, London, UK. pmjourdan@yahoo.no.
Imperial College London · GBMinistry of Public Health · MG

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundSchistosomiasis affects more than 800 million people, mostly in sub-Saharan Africa. A baseline sentinel site study was conducted in the Western half of Madagascar to determine the prevalence and intensity of schistosomiasis and soil-transmitted helminth (STH) infections prior to mass drug administration, and to explore the associations between infection and school attendance, and access to water, sanitation and hygiene (WASH) facilities.

methodsA three-stage, cluster-randomised cross-sectional study was conducted in 29 sentinel sites in October 2015. Twenty school attending and 4 non-attending children in each of the age groups from 7 to 10 years old were randomly selected at each site for detection of Schistosoma haematobium eggs in a single urine slide by filtration, and of S. mansoni, Ascaris lumbricoides, Trichuris trichiura and hookworm eggs in duplicate Kato-Katz slides from a single stool sample. School attendance was registered individually, and school-level access to WASH facilities was scored through pre-defined observed and reported factors. Logistic regression analysis was performed, adjusting for gender, age and study site. School-level WASH status was analysed using Spearman's rank correlation coefficient.

resultsA total of 1,958 children were included. The prevalence of S. haematobium infection and heavy-intensity infection was 30.5% and 15.1%, respectively. The prevalence of S. mansoni infection and heavy-intensity infection was 5.0% and 0.9%, respectively. The prevalence of any STH infection was 4.7%. There was no significant difference in prevalence of infection or heavy-intensity infection of either schistosome species between attending and non-attending children, apart from heavy-intensity S. mansoni infection that was significantly more common in children who did not attend school regularly (aOR = 7.5 (95% CI = 1.1-49.5); p = 0.037). Only a minority of schools had adequate access to WASH facilities, and in this study, we found no significant association between school-level WASH status and schistosomiasis.

conclusionsThis study found an alarmingly high prevalence and intensity of schistosomiasis, and the results warrant urgent scale-up of the national NTD control programme that will need to include both non-attending and attending school-age children in order to reach WHO roadmap targets for the control of schistosomiasis by 2020.

Indexed as

AnimalsChildCross-Sectional StudiesFecesFemaleHumansHygieneMadagascarMalePrevalenceSchistosomaSchistosomiasisSchoolsSoilSoil

Identifiers

PMID26822783
PMCPMC4730633
OpenAlexW2264168751

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.